JP2018536163A5 - - Google Patents

Download PDF

Info

Publication number
JP2018536163A5
JP2018536163A5 JP2018526566A JP2018526566A JP2018536163A5 JP 2018536163 A5 JP2018536163 A5 JP 2018536163A5 JP 2018526566 A JP2018526566 A JP 2018526566A JP 2018526566 A JP2018526566 A JP 2018526566A JP 2018536163 A5 JP2018536163 A5 JP 2018536163A5
Authority
JP
Japan
Prior art keywords
dye
primary antibody
enzyme
tissue sample
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018526566A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018536163A (ja
JP6832930B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/078237 external-priority patent/WO2017085307A1/en
Publication of JP2018536163A publication Critical patent/JP2018536163A/ja
Publication of JP2018536163A5 publication Critical patent/JP2018536163A5/ja
Application granted granted Critical
Publication of JP6832930B2 publication Critical patent/JP6832930B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018526566A 2015-11-22 2016-11-21 Pd−l1陽性腫瘍組織における免疫細胞を同定する方法 Active JP6832930B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562258493P 2015-11-22 2015-11-22
US62/258,493 2015-11-22
PCT/EP2016/078237 WO2017085307A1 (en) 2015-11-22 2016-11-21 Methods of identifying immune cells in pd-l1 positive tumor tissue

Publications (3)

Publication Number Publication Date
JP2018536163A JP2018536163A (ja) 2018-12-06
JP2018536163A5 true JP2018536163A5 (enExample) 2019-11-07
JP6832930B2 JP6832930B2 (ja) 2021-02-24

Family

ID=57391956

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018526566A Active JP6832930B2 (ja) 2015-11-22 2016-11-21 Pd−l1陽性腫瘍組織における免疫細胞を同定する方法

Country Status (7)

Country Link
US (1) US11899016B2 (enExample)
EP (1) EP3377530B1 (enExample)
JP (1) JP6832930B2 (enExample)
AU (1) AU2016357478B2 (enExample)
CA (1) CA3005804C (enExample)
ES (1) ES2886600T3 (enExample)
WO (1) WO2017085307A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2715038C2 (ru) * 2014-07-11 2020-02-21 Дженентек, Инк. Антитела анти-pd-l1 и способы их диагностического применения
IL268781B2 (en) 2017-03-16 2025-09-01 Alpine Immune Sciences Inc Cd80 variant immunomodulatory proteins and uses thereof
WO2019241758A1 (en) 2018-06-15 2019-12-19 Alpine Immune Sciences, Inc. Pd-1 variant immunomodulatory proteins and uses thereof
WO2020061376A2 (en) 2018-09-19 2020-03-26 Alpine Immune Sciences, Inc. Methods and uses of variant cd80 fusion proteins and related constructs
WO2020058308A1 (en) 2018-09-20 2020-03-26 Ventana Medical Systems, Inc. Size-based gating to analyze flow cytometry data
CN112789684B (zh) * 2018-10-01 2025-05-09 文塔纳医疗系统公司 用于预测对pd-1轴导向疗法的应答的方法和系统
JP7479367B2 (ja) 2018-11-29 2024-05-08 ヴェンタナ メディカル システムズ, インク. 代表的なDNAシーケンシングによる個別化されたctDNA疾患のモニタリング
JP2023524568A (ja) * 2020-05-07 2023-06-12 ヴェンタナ メディカル システムズ, インク. 腫瘍試料中のegfrおよびegfrリガンドの発現を評価するための組織化学的システムおよび方法
CN111830256A (zh) * 2020-07-01 2020-10-27 北京基谱生物科技有限公司 一种石蜡切片免疫荧光多重染色试剂盒及使用方法
JPWO2022059601A1 (enExample) * 2020-09-16 2022-03-24
EP4490509A1 (en) * 2022-03-07 2025-01-15 Astrazeneca AB Method for predicting patient response to immunotherapy
EP4490173A1 (en) 2022-03-07 2025-01-15 Alpine Immune Sciences, Inc. Immunomodulatory proteins of variant cd80 polypeptides, cell therapies thereof and related methods and uses
JP2025526652A (ja) * 2022-08-08 2025-08-15 ヴェンタナ メディカル システムズ, インク. デジタル化された病理スライドの定量化のためのシステムおよび方法
WO2024215528A1 (en) 2023-04-13 2024-10-17 Ventana Medical Systems, Inc. Proliferation assay for fixed solid tumors
WO2025193604A1 (en) 2024-03-11 2025-09-18 Ventana Medical Systems, Inc. Non-enzymatic dissociation of ffpe tissue and generation of single cells with intact cell surface markers

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000024760A1 (en) * 1998-10-26 2000-05-04 Ventana Medical Systems, Inc. DETECTION OF HUMAN PAPILLOMA VIRUS IN PAPANICOLAOU (Pap) SMEARS
US6544798B1 (en) 1999-02-26 2003-04-08 Ventana Medical Systems, Inc. Removal of embedding media from biological samples and cell conditioning on automated staining instruments
US6195451B1 (en) * 1999-05-13 2001-02-27 Advanced Pathology Ststems, Inc. Transformation of digital images
US8071322B2 (en) * 2002-11-12 2011-12-06 Epitomics, Inc. Method for identifying differentially expressed proteins
JP2013531801A (ja) * 2010-07-02 2013-08-08 ヴェンタナ メディカル システムズ, インク. 標的検出のためのハプテンコンジュゲート
JP6101782B2 (ja) * 2012-03-27 2017-03-22 ヴェンタナ メディカル システムズ, インク. シグナリングコンジュゲート及び使用法
KR102702287B1 (ko) * 2012-05-15 2024-09-04 브리스톨-마이어스 스큅 컴퍼니 Pd-1/pd-l1 신호전달을 방해하는 것에 의한 암 면역요법
WO2014194293A1 (en) * 2013-05-30 2014-12-04 Amplimmune, Inc. Improved methods for the selection of patients for pd-1 or b7-h4 targeted therapies, and combination therapies thereof
WO2015013388A2 (en) * 2013-07-24 2015-01-29 Dana-Farber Cancer Institute, Inc. Anti-galectin-1 monoclonal antibodies and fragments thereof
EP3079772B1 (en) * 2013-12-10 2020-02-05 Merck Sharp & Dohme Corp. Immunohistochemical proximity assay for pd-1 positive cells and pd-ligand positive cells in tumor tissue
ES2713438T3 (es) * 2014-02-24 2019-05-21 Ventana Med Syst Inc Amplificación de señal de análogos de quinona metidas

Similar Documents

Publication Publication Date Title
JP2018536163A5 (enExample)
Kalina et al. Relevance of antibody validation for flow cytometry
Arola et al. Specific noncompetitive immunoassay for HT-2 mycotoxin detection
JP2012510618A5 (enExample)
Wang et al. Biosensors for the detection of Bacillus anthracis
HRP20160461T1 (hr) Solubilna humana st-2 antitijela i eseji
Adler et al. A natively paired antibody library yields drug leads with higher sensitivity and specificity than a randomly paired antibody library
WO2012056407A8 (en) Antibodies which bind soluble t-cell receptor ligands
JP2011524537A5 (enExample)
JP2015502547A5 (enExample)
US20170176423A1 (en) Magnetic programmable bead enzyme-linked immunosorbent assay
Li et al. Single-step and highly sensitive imaging of exosomal PD-L1 through aptamer-activated cascade primer exchange reaction-generated branched DNA nanostructures
Wu et al. Magnetic-based enrichment of rare cells from high concentrated blood samples
Andersson et al. Assaying cardiac biomarkers for toxicity testing using biosensing and cardiomyocytes derived from human embryonic stem cells
JP2017026631A5 (enExample)
Zhao et al. Digital-resolution and highly sensitive detection of multiple exosomal small RNAs by DNA toehold probe-based photonic resonator absorption microscopy
CN109416356A (zh) 使用ip-质谱法的抗体验证
Lyu et al. Generation and screening of antigen-specific nanobodies from mammalian cells expressing the BCR repertoire library using droplet-based microfluidics
Wang et al. A magnetic-optical triple-mode lateral flow immunoassay for sensitive and rapid detection of respiratory adenovirus
WO2010128506A3 (en) Means and methods for recognizing the development of cardiovascular disease in an individual
CN107937490A (zh) 一种非对称pcr的试纸条检测植物病原菌的方法及试剂盒
Wei et al. Ultrasensitive “Hunter of Target”: Rabbit Monoclonal Antibody-Based Competitive Lateral Flow Immunoassay for Saxitoxin
Gulinaizhaer et al. Detection of monkeypox virus using helicase dependent amplification and recombinase polymerase amplification combined with lateral flow test
Al-Amin et al. Sensitive protein detection using site-specifically oligonucleotide-conjugated nanobodies
Ren et al. A Portable Nucleic Acid Sensor Based on PCR for Simple, Rapid, and Sensitive Testing of Botrytis cinerea in Ginseng